While the company defended the price as cost effective, the treatment ranks as one of the most expensive medicines in the world on a single-use basis.The first gene therapy for Duchenne muscular dystrophy will cost $3.2 million, its developer, biotechnology company Sarepta Therapeutics, said on Thursday.The price makes the drug, named Elevidys and approved by […]
